The Plasma Assays Market, in the next 10 years, is expected to substantiate. Hospital decision support solutions are being floated, and the status quo is expected to stay the same even going forward. Herein, value propositions are made to the society on the whole and patients in particular by the government, private insurance companies, and social security organizations working in unison. As such, the healthcare industry is expected to witness a good number of clinical outcomes in the forthcoming period.
The COVID-19 outbreak has put tremendous pressure on healthcare services. Despite lockdown and disruption in the supply chain, the COVID 19 pandemic has encouraged the major market players to focus on research and development of various advanced testing technologies.
For instance, in May 2020, the DarioHealth Corp. announced the FDA approval for the use of self-test plasma glucose meters by the diabetes patients in the hospitals. These meters were intended to limit the exposure to the COVID 19 viral infection, by self-diagnosing the blood-glucose levels.
Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32459
Globally, the plasma assays market is primarily driven by increasing prevalence of chronic diseases like cardiovascular disease, and diabetes. Public awareness related to the complications concerned with chronic diseases and early diagnosis is the major factors that fuel the plasma assays market growth.
Conversely, the rising focus on research activities and advancement for the early detection of infectious agents in plasma is expected to render lucrative opportunities during the forecast period. The costs of handling the equipment for plasma assay may restrain the plasma market growth during the forecast.
Market Segmentation
The global plasma assays market is segmented based on test type, method, end-user, and region.
Based on the test type the plasma assays market is segmented as:
- Complete Blood Count (CBC)
- Glucose testing
- Basic Metabolic Panel (BMP)
- Lipid Panel testing
- Blood Urea Nitrogen Testing (BUN)
- Coagulation Test
- Electrolyte Test
- Thyroid Function Test
- Others
Based on methods, the plasma assays market is segmented as:
- Manual
- Automated
Based on end-user, the plasma assays market is segmented as:
- Hospitals
- Clinics
- Diagnostic centres
- Research Labs
Request for Table of Content@ https://www.persistencemarketresearch.com/toc/32459
The glucose testing segment accounted higher share in the plasma assays market owing to the rising prevalence of chronic disease like diabetes among the growing population including adults as well as the children and increasing awareness among the people.
Rising demand towards the advanced technology and point of care service with advance treatment witnessed the automated plasma assay method to dominate the plasma assays market in terms of methods used for the plasma detection during the forecast period.
Diagnostic centres segment is projected to hold the largest share in the plasma assays market owing to the increasing preference towards testing the accuracy of laboratory tests and diminished turnaround time expects the diagnostic centres to surge the plasma assays market during the forecast period.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, test type, methods, and end-users.
Also, favourable government initiatives and CLIA waiver on diagnostic devices is a driving factor that expects to boost the plasma assays market growth. Asia-pacific region accounted for high growth owing to the rising prevalence of chronic diseases among the growing population and increasing investment on the healthcare facilities anticipates the faster growth of the region.
For instance, in October 2020, Siemens Healthier, a subsidiary of Siemens AG announced to expand its molecular assays manufacturing in India to develop the plasma, antigen-antibody testing for COVID 19. Europe plasma assays market is expected to gain significant traction with increasing interest towards the advanced medical procedures in the region.
Latin America and Middle East & Africa are the least lucrative regions owing to poor access to healthcare facilities in the region.
Access Full Report@ https://www.persistencemarketresearch.com/checkout/32459
- Abbott Diagnostics
- Roche Diagnostics
- Danaher Corporation
- Bio-Rad Laboratories Inc.
- Quest Diagnostics
- Thermo Fisher Scientific Inc.
- Biomerica Inc.
- Becton Dickinson & Company
- BioMerieux S.A.
- Siemens Healthcare
- Trinity Biotech PLC
- Others
About Us: Persistence Market Research
Contact Us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Japan Office: 1-2-1 Kinshi Arca Central Building
14/F Tokyo, 130-0013, Japan
Call 1-888-863-3700
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com